Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,478,999
+$2,762,250 QoQ
Shares Held
90,858
+27.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#408
of 2,266 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Sep 30, 2020CallValue
$22,116,500
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $87,605,755 across 4 Drug Manufacturers - General names. GILD ranks #4 (13.1% of the industry book) .
All Filings in GILD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,478,999 | 90,858 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $8,716,749 | 71,018 | Shares | Defined | 2026-02-17 | |
| 2022-03-31 | $14,855,603 | 249,884 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,590,461 | 76,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $46,562,079 | 666,601 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $45,902,144 | 666,601 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $69,481,321 | 1,075,063 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $54,861,927 | 941,674 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $22,116,500 | 350,000 | Call | Defined | 2020-11-16 | |
| 2020-09-30 | $68,124,443 | 1,078,089 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $51,812,319 | 673,412 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $41,367,623 | 553,339 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||